A PYMNTS Company

Germany: Bain and Cinven win bidding war for Stada

By  |  April 10, 2017

Bain Capital and Cinven have won a fierce bidding war for Germany’s Stada after beating a rival private equity consortium with a €4.1 billion takeover offer for the maker of generic versions of drugs such as Viagra.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The boards of Stada said on Monday that the €66 a share bid from Bain and Cinven had been chosen over a proposal from Advent International and Permira because it was “the most financially appealing”.

    One person close to the process said that the months-long battle culminated in a flurry of activity over the weekend, with Bain and Cinven eventually being declared the winner at 5am German time Monday morning.

    The offer is a 48.9 per cent premium to Stada’s undisturbed share price, marking a victory for Carl Ferdinand Oetker, chairman of the German drugmaker, who argued that the company deserved a higher valuation after rejecting earlier bids of €58 a share from the two consortiums in March.

    Full Content: Financial Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.